Nuvelo to Present at the CIBC World Markets Fourteenth Annual Healthcare Conference
Friday November 7, 9:30 am ET
SUNNYVALE, Calif., Nov. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO - News) today announced that Dr. Ted W. Love, president and CEO, will be presenting at the CIBC World Markets Fourteenth Annual Healthcare Conference on Tuesday, November 11, 2003 at 2:00 p.m. Eastern Time at The Plaza Hotel in New York City.
Dr. Love will provide a brief corporate overview and discuss the company's near-term milestones, including an update on its two Phase 2 clinical trials with lead product candidate, alfimeprase.
A live audio webcast of the presentation will be available online at veracast.com . You can also access the webcast via the Investor Relations portion of the Nuvelo Web site at www.nuvelo.com.
About Nuvelo
Nuvelo, Inc., formed by the merger of Hyseq Pharmaceuticals, Inc. and VARIAGENICS, Inc., is engaged in the discovery, development and commercialization of life improving therapeutics for the treatment of human disease. Nuvelo's lead product candidate, alfimeprase, is partnered with Amgen and is currently in two Phase 2 trials in two indications, peripheral arterial occlusion and catheter occlusion. Additional programs include drug discovery focused on antibody targets and secreted proteins.
Information about Nuvelo is available at our new Web site at www.nuvelo.com or by phoning 408-215-4000.
Source: Nuvelo, Inc. |
